THE NEW HAZLETT CENTER FOR THE PERFORMING ARTS AND ITS AFFILIATED COMPANIES DISCLAIM ALL WARRANTIES, REPRESENTATIONS OR ENDORSEMENTS, EXPRESSED OR IMPLIED, WITH REGARD TO THE DATA, INFORMATION AND MATERIAL INCLUDED IN, OR ACCESSIBLE FROM, THIS WEBSITE OR THE INTERNET, INCLUDING, BUT NOT LIMITED TO, ALL IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT
PSCI, post-stroke cognitive impairment
The reason given was withdrawal of the original Category 2 nominations, not a positive safety determination
3.4 Pharmacological treatment of hyperuricemia 3.4.1 Conventional agents and mechanisms of action Pharmacotherapy for hyperuricemia involves multiple mechanisms and drug classes, primarily targeting urate production inhibition, uricosuric effects, and metabolic pathway modulation (Wu D
E.AnsteyK
17 DuvoixA.MorceauF.DelhalleS.SchmitzM.SchnekenburgerM.GalteauM